TURKISH JOURNAL OF NEUROLOGY, cilt.24, sa.1, ss.38-42, 2018 (ESCI)
Objective: We aimed to evaluate the outcomes of two groups of patients with acute ischemic stroke who were treated with intravenous recombinant tissue-plasminogen activator (IV rt-PA); those with isolated middle cerebral artery (MCA) occlusion and those without any large vessel occlusion.